OAKVILLE, ON, Feb. 20, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced the details of its Q4 2020 financial results conference call on Thursday, March 26, 2019.
CONFERENCE CALL DETAILS | |
DATE: | Thursday, March 26, 2020 |
TIME: | 8:30 a.m. EDT |
DIAL IN NUMBER: | (416) 764-8688 or (888) 390-0546 |
CONFERENCE ID: | 02880904 |
REPLAY: | (888) 390-0541 (playback code 880904 #) |
Available until midnight April 2, 2020 | |
WEBCAST: | The audio webcast can be accessed at http://cipher.investorroom.com/ under Investor Relations or at https://event.on24.com/wcc/r/2203231/4C6EB61DB02BC18A6F5927498CF2787D |
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
View original content: http://www.newswire.ca/en/releases/archive/February2020/20/c0808.html
James Bowen, CFA, LodeRock Advisors, 416-519-9442, [email protected] CNW Group 2020